- On Announcement of All Oral MDR TB regimen by Indian Government
- Modi visit to US: Trump appearance signals importance of India
- After ‘Howdy Modi’, Trump and Modi likely to sign trade deal
- US – India Relations: President Trump To Sign New Trade Deal With Indian PM Modi?
- India-US trade talks: Trading lives?
Category Archives: Access to Medicins
Source: Health Policy Watch 21st August 2019 The US Food and Drug Administration (FDA) last week approved a tuberculosis (TB) treatment regimen containing a new drug, pretomanid, offering a shorter, more effective course of treatment for highly drug-resistant strains of TB, … Continue reading
Source: Third World Network 13th August, 2019 TWN Info Service on Health Issues (May19/03) 9 May 2019 Third World Network Shri J. P. Nadda Hon’ble Minister of Health and Family Welfare Room No. 348, ‘A’ Wing Nirman Bhavan, New Delhi-110011 … Continue reading
Source: Health Policy Watch 23rd July, 2019 WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and … Continue reading
Source: Keionline 24th May, 2019 On Thursday May 23, 2019, KEI, Doctors without Borders/Médecins Sans Frontières (MSF), and 44 more organizations and 10 individuals released an open letter to delegates of the 72nd World Health Assembly urging them to support … Continue reading
Source: Keionline 24th May, 2019 On Wednesday May 22, 2019, KEI delivered the following intervention at the 72nd World Health Assembly for the agenda item, “11.5 – Universal Health Coverage.” A PDF version is available here. KEI Statement – WHA72 11.5 … Continue reading
Source: Keionline 21st May, 2019 24 May 2019- KEI panel discussion- Assessing the implications of the development of new cell and gene-based therapies (including CART and CRISPR): What role should WHO play? On Friday, 24 May 2019, Knowledge Ecology International … Continue reading
Source: Health Policy Watch 20th May, 2019 Health Policy Watch is publishing in an open-access format the latest draft of the World Health Assembly resolution on transparency of drug costs. The new draft, now available to all, reflects changes from … Continue reading